A Novel Index for Staging Hepatitis B Related Liver Cirrhosis in Patients with Hepatocellular Carcinoma

Overview

Journal Sci Prog

Publisher Sage Publications

Specialty Science

Date 2021 May 18

PMID 34003700

Authors

Juanhua Wu

Yunyang Chen

Chaohai Zuo

Naile Kuang

Ronggang Li

Qing Li

Jianqiu Ruan

Enming Cui

Ruiyun Xu

Jiexiong Yu

Affiliations

Soon will be listed here.

Abstract

Information on the stage of liver cirrhosis is essential for prognostication and decisions on surgical planning for hepatocellular carcinoma (HCC) patients. But a non-invasive liver cirrhosis staging model is still lacking. The aim of our study was to develop a non-invasive model based on routine clinical parameters to evaluate the severity of cirrhosis in hepatitis B related HCC patients. A total of 226 HCC patients with chronic hepatitis B virus (HBV) infection who had liver resection were analyzed in this retrospective study. We found that platelets, prothrombin activity, maximum oblique diameter of right hepatic lobe and spleen length were the independent predictors of liver cirrhosis in HCC patients. By cumulating the weight of risk scores of independent variables, we constructed the PPMS (PLT/PTA/maximum oblique diameter of right hepatic lob/spleen length) index. The areas under the receiver operating characteristic curves (AUROC) of PPMS index were 0.820, 0.667, and 0.650 in predicting ≥cirrhosis 1 (C1), ≥cirrhosis 2 (C2), and ≥cirrhosis 3 (C3), respectively. The optimal cut-off value of the PPMS index for predicting ≥C1, ≥C2, and ≥C3 was 4.392, 4.471, and 4.784, respectively. And the corresponding sensitivity was 63.1%, 63.2%, and 64.7%, the corresponding specificity was 89.4%, 64.3%, and 62.5%, respectively. Our study constructed a non-invasive liver cirrhosis index (PPMS) could distinguish patients from different stages of liver cirrhosis, which might add more preoperative information for HCC patients.

References

Liu P, Li P, He W, Zhao L . Liver and spleen volume variations in patients with hepatic fibrosis. World J Gastroenterol. 2009; 15(26):3298-302. PMC: 2710787. DOI: 10.3748/wjg.15.3298. View

Sharma S, Khalili K, Nguyen G . Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol. 2014; 20(45):16820-30. PMC: 4258552. DOI: 10.3748/wjg.v20.i45.16820. View

Goshima S, Kanematsu M, Watanabe H, Kondo H, Kawada H, Moriyama N . Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio. J Magn Reson Imaging. 2012; 36(5):1148-53. DOI: 10.1002/jmri.23758. View

Lin Z, Xin Y, Dong Q, Wang Q, Jiang X, Zhan S . Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011; 53(3):726-36. DOI: 10.1002/hep.24105. View

Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V . FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007; 46(1):32-6. DOI: 10.1002/hep.21669. View

Ouyang G, Zhang Y, Zhu S, Wang P, Ren Y, Li J . A novel, non-invasive model for diagnosing liver fibrosis stage in patients with hepatocellular carcinoma. Sci Rep. 2018; 8(1):13074. PMC: 6117345. DOI: 10.1038/s41598-018-31351-3. View

Kim S, Oh H, Wanless I, Lee S, Han K, Park Y . The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. J Hepatol. 2012; 57(3):556-63. DOI: 10.1016/j.jhep.2012.04.029. View

Kim M, Cho M, Baik S, Park H, Jeon H, Im C . Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol. 2011; 55(5):1004-9. DOI: 10.1016/j.jhep.2011.02.012. View

Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J . The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2015; 65(8):1369-76. PMC: 4975834. DOI: 10.1136/gutjnl-2015-309260. View

10.

van Mierlo K, Schaap F, Dejong C, Olde Damink S . Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure. J Hepatol. 2016; 65(6):1217-1231. DOI: 10.1016/j.jhep.2016.06.006. View

11.

Yan S, Fan J, Qio L . Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic. Curr Cancer Drug Targets. 2016; 17(6):505-511. DOI: 10.2174/1568009616666160926124530. View

12.

. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015; 63(1):237-64. DOI: 10.1016/j.jhep.2015.04.006. View

13.

Llovet J, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M . Hepatocellular carcinoma. Nat Rev Dis Primers. 2016; 2:16018. DOI: 10.1038/nrdp.2016.18. View

14.

Wai C, Greenson J, Fontana R, Kalbfleisch J, Marrero J, Conjeevaram H . A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2):518-26. DOI: 10.1053/jhep.2003.50346. View

15.

Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, Suzuki F . Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999; 94(7):1918-22. DOI: 10.1111/j.1572-0241.1999.01231.x. View

16.

Yang J, Kim W, Coelho R, Mettler T, Benson J, Sanderson S . Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2010; 9(1):64-70. PMC: 3951426. DOI: 10.1016/j.cgh.2010.08.019. View

17.

Boursier J, de Ledinghen V, Leroy V, Anty R, Francque S, Salmon D . A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis. J Hepatol. 2017; 66(6):1158-1165. DOI: 10.1016/j.jhep.2017.01.003. View

18.

DAmico G, Garcia-Tsao G, Pagliaro L . Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2005; 44(1):217-31. DOI: 10.1016/j.jhep.2005.10.013. View

19.

Child C, Turcotte J . Surgery and portal hypertension. Major Probl Clin Surg. 1964; 1:1-85. View

20.

Latorre R, Vaquero J, Rincon D, Puerto M, Ponce M, Sarnago F . Determinants of platelet count are different in patients with compensated and decompensated cirrhosis. Liver Int. 2015; 36(2):232-9. DOI: 10.1111/liv.12908. View